Skip to main content

Table 7 Summary of clinical practice recommendations and issues to be addressed in future (prospective) studies

From: Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice

 

Clinical practice recommendation

Issues to be addressed in future studies

Diagnosis

•NBS via SA to avoid sequelae including HCC

 

Treatment & Monitoring

•NTBC & diet

•Calculation Tyr & Phe vs protein restriction

•NTBC-level 20-40 μM

•NTBC-target level

•Tyr-level < 400 μM

•Tyr-target level

•SA below detection limit

•SA target level

•Contrast enhanced ultrasound & AFP

•Correlation NTB-levels & side effects

•Liver & Kidney function

•NTBC- pharmacokinetics in children

Liver transplantation

•HCC

•NTBC & diet if SA-elevation post transplant

•Therapy resistance

Outcome

•Psychomotor/neurocognitive assessment

•Pathophysiology of neurological damage and risk factors

•Definition of adequate test battery

Reimbursement

•Diagnosis & Treatment & Monitoring

Â